Literature DB >> 31255926

Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.

Seyed-Omar Zaraei1, Abduelmula R Abduelkarem2, Hanan S Anbar3, Sara Kobeissi2, Miami Mohammad2, Aya Ossama2, Mohammed I El-Gamal4.   

Abstract

In the present article, we reviewed the sulfamate-containing compounds reported as bioactive molecules. The possible molecular targets of sulfamate derivatives include steroid sulfatase enzyme, carbonic anhydrases, acyl transferase, and others. Sulfamate derivatives can help treat hormone-dependent tumors including breast, prostate, and endometrial cancers, Binge eating disorder, migraine, glaucoma, weight loss, and epilepsy. Sulfamate derivatives can act also as calcium sensing receptor agonists and can aid in osteoporosis. Furthermore, acyl sulfamate derivatives can act as antibacterial agents against Gram-positive bacteria. A recent study revealed a new side effect of topiramate, a sulfamate-containing compound, which is sialolithiasis. The structural and biological characteristics of the reviewed compounds are presented in detail.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-cancer; Carbonic anhydrase; Irosustat; Steroid sulfatase; Sulfamate; Topiramate

Mesh:

Substances:

Year:  2019        PMID: 31255926     DOI: 10.1016/j.ejmech.2019.06.052

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Synthesis, carbonic anhydrase inhibition, anticancer activity, and molecular docking studies of 1,3,4-oxadiazole derivatives.

Authors:  Balasaheb D Vanjare; Nam Gyu Choi; Young Seok Eom; Hussain Raza; Mubashir Hassan; Ki Hwan Lee; Song Ja Kim
Journal:  Mol Divers       Date:  2022-03-28       Impact factor: 2.943

2.  New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1H-1,2,3-triazol-4-yl)naphthalen-2-yl sulphamate derivatives.

Authors:  Olga Ciupak; Mateusz Daśko; Karol Biernacki; Janusz Rachon; Maciej Masłyk; Konrad Kubiński; Aleksandra Martyna; Sebastian Demkowicz
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

3.  Enaminone-based carboxylic acids as novel non-classical carbonic anhydrases inhibitors: design, synthesis and in vitro biological assessment.

Authors:  Mahmoud F Abo-Ashour; Hadia Almahli; Alessandro Bonardia; Amira Khalil; Tarfah Al-Warhi; Sara T Al-Rashood; Hatem A Abdel-Aziz; Alessio Nocentini; Claudiu T Supuran; Wagdy M Eldehna
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.